Evidence map›Paper›PMID 41669612›Full record

ArticleNeuroscience applied2026

Virtual reality-based cognitive screening in psychiatry: Investigating optimal cut-offs for cognitive impairment in bipolar disorder.

Andreas Elleby Jespersen, Julie Marie Lindhardsen, Anders Lumbye, Viktoria Damgaard, Johanna Mariegaard Schandorff, Christina Mikkelsen, Maria Didriksen, Sisse Rye Ostrowski, Lars Vedel Kessing, Kamilla Woznica Miskowiak

Abstract read
In one paragraph

Article in Neuroscience applied, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andreas Elleby JespersenNeurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, Copenhagen, Denmark.
Julie Marie LindhardsenDepartment of Psychology, University of Copenhagen, Copenhagen, Denmark.
Anders LumbyeWide Angle Media, Copenhagen, Denmark.
Viktoria DamgaardNeurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, Copenhagen, Denmark.
Johanna Mariegaard SchandorffNeurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, Copenhagen, Denmark.
Christina MikkelsenDepartment of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark.
Maria DidriksenDepartment of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark.
Sisse Rye OstrowskiDepartment of Clinical Immunology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark.
Lars Vedel KessingDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Kamilla Woznica MiskowiakNeurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive impairment is a key treatment target across neuropsychiatric disorders, including bipolar disorder (BD), but standard neuropsychological tools often fail to capture real-world cognitive challenges. Virtual reality (VR) offers a more ecologically valid alternative. This study investigated the optimal cut-off score of the novel Cognition Assessment in Virtual Reality (CAVIR) test for detecting impaired functional cognitive capacity in BD. Cut-off scores on the CAVIR were investigated in a sample of outpatients with BD (primary clinical screening BD sample;

Indexed as

Bipolar disorderCognitionCognitive impairmentCognitive screeningEcological validityMood disordersVirtual reality

Identifiers

PMID41669612
PMCPMC12885629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.